Treatment of non-alcoholic fatty liver disease - Current perspectives

Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology
Anshuman Elhence, Shalimar

Abstract

Therapeutics aimed at treating non-alcoholic fatty liver disease (NAFLD) target the pathogenic process from deranged metabolism leading to steatosis to cell stress and death, leading to a cascade of inflammation and fibrosis, ultimately culminating into cirrhosis. The development of drugs for management of NAFLD has bloomed over the past decade, although at present there is no approved pharmacological agent for its management. Not all patients with the disease progress to cirrhosis and decompensation; hence, treatment specifically is provided for those with a high risk of progression such as those with biopsy-proven steatohepatitis or fibrosis. Along with disease-specific management, all patients must receive therapies directed at risk factors such as dyslipidemia, insulin resistance, type 2 diabetes mellitus and obesity. Comorbidities such as cardiovascular disease, sleep apnoea and chronic kidney disease need management. A current perspective on the therapeutic options is detailed in this review.

References

Jan 16, 2007·Digestive Diseases and Sciences·David TendlerEric C Westman
Jul 19, 2008·The New England Journal of Medicine·Iris ShaiUNKNOWN Dietary Intervention Randomized Controlled Trial (DIRECT) Group
Mar 12, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kausik DasAbhijit Chowdhury
Apr 30, 2010·The New England Journal of Medicine·Arun J SanyalUNKNOWN NASH CRN
Jun 26, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Giovanni MussoGianfranco Pagano
Dec 31, 2010·Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology·Ajay Duseja
Jul 26, 2011·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Jeffrey D Mosko, Geoffrey C Nguyen
Oct 19, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Vlad RatziuMario Chojkier
Mar 31, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Naim Alkhouri, Ariel E Feldstein
May 5, 2012·Journal of Gastroenterology and Hepatology·Young-Joo JinDong-Jin Suh
Feb 1, 2013·Annals of the New York Academy of Sciences·Howard C Masuoka, Naga Chalasani
Jan 10, 2014·The American Journal of Clinical Nutrition·Tannaz EslamparastAzita Hekmatdoost
Feb 28, 2014·World Journal of Gastroenterology : WJG·Juan DuYou-Ming Li
Apr 2, 2014·Liver International : Official Journal of the International Association for the Study of the Liver·Min-Sun KwakJung-Hwan Yoon
May 13, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Rifaat SafadiUNKNOWN FLORA Group
Aug 16, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mattias EkstedtRolf Hultcrantz
Oct 2, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sechang OhJunichi Shoda
Feb 24, 2015·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Michael SubichinAdrian Dan
Apr 14, 2015·Gastroenterology·Eduardo Vilar-GomezManuel Romero-Gomez
May 20, 2015·Journal of Hepatology·Paola DongiovanniLuca Valenti
Jun 5, 2015·European Journal of Gastroenterology & Hepatology·Venkatanarayana GangarapuHakan Şenturk
Jul 22, 2015·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Sahil MittalJessica A Davila
Aug 15, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair M YounossiSharon Hunt
Dec 29, 2015·Digestive Diseases and Sciences·Pierre BlaisFasiha Kanwal
Dec 29, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair M YounossiMark Wymer
Mar 15, 2016·Gastroenterology·Guillaume LassaillyPhilippe Mathurin
Apr 12, 2016·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver (EASL)UNKNOWN European Association for the Study of Obesity (EASO)
May 18, 2016·The American Journal of Gastroenterology·Yoosoo ChangSeungho Ryu
Jun 22, 2016·Metabolism: Clinical and Experimental·Judith Aron-WisnewskyJean-Louis Pépin
Sep 2, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Donghee Kim, W Ray Kim
Nov 9, 2016·European Journal of Gastroenterology & Hepatology·Karn WijarnpreechaPatompong Ungprasert
Jan 5, 2017·Liver International : Official Journal of the International Association for the Study of the Liver·Abdul M Oseini, Arun J Sanyal
Jun 24, 2017·Journal of Hepatology·Jian-Gao FanVincent Wai-Sun Wong
Jul 18, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Naga ChalasaniArun J Sanyal
Aug 24, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Scott L FriedmanEric Lefebvre
Sep 12, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Rohit LoombaUNKNOWN GS-US-384-1497 Investigators

❮ Previous
Next ❯

Citations

Jun 24, 2020·The Annals of Pharmacotherapy·John A DoughertyKrisy-Ann Thornby
Jul 4, 2020·Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology·Ajit Venniyoor
Jul 6, 2020·Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology·Anshuman Elhence, Shalimar
Mar 28, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Nalini SodumC Mallikarjuna Rao

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Related Papers

Expert Review of Endocrinology & Metabolism
Sohrab Rahimi Naini, Michael Fuchs
World Journal of Gastrointestinal Pathophysiology
Rashmee Patil, Gagan K Sood
Liver International : Official Journal of the International Association for the Study of the Liver
Nahum Méndez-SánchezMisael Uribe
Seminars in Gastrointestinal Disease
Stephen A Harrison, Anna Mae Diehl
© 2021 Meta ULC. All rights reserved